ABFERO LIMITED

Unknown (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£252,514

Nov 20 - Apr 24

Novel Parkinson’s Disease therapy targeting iron-related cell death and alphasynuclein aggregation (PD-IRONSYN)

Innovate UK award to ABFERO LTD and David Jones

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}